FDA Considers OTC Use for Opioid Overdose Reversal Drug

Published on November 15, 2022

The FDA is exploring the possibility of allowing certain forms of the opioid overdose reversal drug naloxone to be sold over-the-counter. This development could potentially make naloxone more accessible to the public in emergency situations. Similar to how a fire extinguisher can be obtained without a prescription, naloxone kits could become readily available at pharmacies or even convenience stores. Although further data is required to determine the safety and efficacy of specific products, this move by the FDA signals a significant step towards addressing the opioid crisis. OTC availability of naloxone would empower individuals to take immediate action and save lives in cases of opioid overdose. It would be akin to having a life preserver readily accessible for anyone near water. With naloxone more easily accessible, more lives can potentially be saved. To learn more about this bold move by the FDA and the potential impact it may have on combating the opioid crisis, dive into the underlying research and stay informed!

Opioid overdose reversal drug naloxone may be safe and effective for over-the-counter use in some forms, the U.S. Food and Drug Administration (FDA) said on Tuesday, potentially paving the way for its use federally. The FDA would still require data on individual products…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>